CIAS
ELV icon

Capital Investment Advisory Services’s Elevance Health ELV Stock Holding History

Capital Investment Advisory Services’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Sell
750
-34
-4% -$12.6K 0.02% 594
2026
Q1 		$229K Buy
784
+2
+0.3% +$657 0.02% 586
2025
Q4 		$274K Sell
782
-784
-50% -$265K 0.02% 519
2025
Q3 		$506K Buy
1,566
+638
+69% +$198K 0.04% 359
2025
Q2 		$361K Sell
928
-67
-7% -$26.9K 0.03% 409
2025
Q1 		$433K Buy
995
+10
+1% +$4.01K 0.04% 354
2024
Q4 		$363K Sell
985
-37
-4% -$15.5K 0.04% 359
2024
Q3 		$531K Buy
1,022
+33
+3% +$17.6K 0.05% 285
2024
Q2 		$536K Hold
989
– – 0.06% 280
2024
Q1 		$513K Sell
989
-47
-5% -$23.4K 0.05% 290
2023
Q4 		$489K Buy
1,036
+24
+2% +$11.1K 0.05% 297
2023
Q3 		$441K Buy
1,012
+20
+2% +$9.07K 0.04% 304
2023
Q2 		$441K Hold
992
– – 0.04% 293
2023
Q1 		$456K Sell
992
-70
-7% -$33.3K 0.05% 276
2022
Q4 		$545K Sell
1,062
-328
-24% -$167K 0.06% 252
2022
Q3 		$631K Buy
1,390
+14
+1% +$6.7K 0.08% 213
2022
Q2 		$664K Hold
1,376
– – 0.08% 210
2022
Q1 		$676K Hold
1,376
– – 0.07% 227
2021
Q4 		$638K Sell
1,376
-56
-4% -$23.6K 0.08% 238
2021
Q3 		$534K Hold
1,432
– – 0.07% 252
2021
Q2 		$547K Buy
1,432
+328
+30% +$125K 0.07% 258
2021
Q1 		$396K Hold
1,104
– – 0.06% 285
2020
Q4 		$354K Buy
1,104
+180
+19% +$55.2K 0.05% 302
2020
Q3 		$248K Sell
924
-225
-20% -$60.5K 0.05% 309
2020
Q2 		$302K Sell
1,149
-25
-2% -$6.67K 0.06% 246
2020
Q1 		$267K Buy
1,174
+500
+74% +$136K 0.07% 241
2019
Q4 		$204K Hold
674
– – 0.05% 293
2019
Q3 		$162K Sell
674
-140
-17% -$38.4K 0.05% 305
2019
Q2 		$246K Buy
814
+240
+42% +$65.6K 0.07% 241
2019
Q1 		$165K Sell
574
-21
-4% -$6.07K 0.06% 243
2018
Q4 		$156K Sell
595
-248
-29% -$68.2K 0.07% 229
2018
Q3 		$231K Hold
843
– – 0.11% 192
2018
Q2 		$201K Buy
+843
New +$195K 0.1% 198

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Capital Investment Advisory Services's ELV Position: Q2 2026 in Review

Capital Investment Advisory Services reduced its Elevance Health (ELV) stake by 4.3% in Q2 2026, selling an estimated $12.6K and leaving 750 shares worth $290K. The position accounts for 0.02% of the portfolio, ranked #594.

Capital Investment Advisory Services first reported a position in ELV in Q2 2018 and has held it in 33 quarters since. The position peaked at $676K in Q1 2022. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capital Investment Advisory Services held 750 shares of Elevance Health worth $290K as of Q2 2026.
  • Capital Investment Advisory Services sold 34 Elevance Health shares in Q2 2026, an estimated $12.6K.
  • Elevance Health made up 0.02% of Capital Investment Advisory Services's portfolio in Q2 2026, its #594 holding.
  • Capital Investment Advisory Services first reported a position in Elevance Health in Q2 2018 and has held it in 33 quarters since.
  • Capital Investment Advisory Services's Elevance Health position peaked at $676K in Q1 2022.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.